Your browser doesn't support javascript.
Should we try the antiinflammatory natural product, celastrol, for COVID-19?
Habtemariam, Solomon; Nabavi, Seyed Fazel; Berindan-Neagoe, Ioana; Cismaru, Cosmin Andrei; Izadi, Morteza; Sureda, Antoni; Nabavi, Seyed Mohammad.
  • Habtemariam S; Pharmacognosy Research Laboratories and Herbal Analysis Services, University of Greenwich, Kent, UK.
  • Nabavi SF; Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Berindan-Neagoe I; Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Cismaru CA; Research Center for Advanced Medicine - Medfuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Izadi M; The Functional Genomics and Experimental Pathology, The Oncology Institute "Prof. Dr. Ion Chiricuta", Cluj-Napoca, Romania.
  • Sureda A; Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Nabavi SM; Department of Functional Sciences, Immunology and Allergology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Phytother Res ; 34(6): 1189-1190, 2020 06.
Article in English | MEDLINE | ID: covidwho-141592

Full text: Available Collection: International databases Database: MEDLINE Main subject: Triterpenes / Severe acute respiratory syndrome-related coronavirus Limits: Humans Language: English Journal: Phytother Res Journal subject: Complementary Therapies Year: 2020 Document Type: Article Affiliation country: Ptr.6711

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Triterpenes / Severe acute respiratory syndrome-related coronavirus Limits: Humans Language: English Journal: Phytother Res Journal subject: Complementary Therapies Year: 2020 Document Type: Article Affiliation country: Ptr.6711